Coloplast A/S (OTCMKTS:CLPBY) Short Interest Down 12.1% in July

Coloplast A/S (OTCMKTS:CLPBY) was the target of a large decline in short interest during the month of July. As of July 15th, there was short interest totalling 79,700 shares, a decline of 12.1% from the June 30th total of 90,700 shares. Based on an average trading volume of 134,500 shares, the days-to-cover ratio is currently 0.6 days.

Coloplast A/S Stock Up 0.8 %

CLPBY traded up $0.10 during trading hours on Wednesday, hitting $12.96. 44,062 shares of the stock were exchanged, compared to its average volume of 55,532. The stock has a 50-day simple moving average of $12.38 and a 200-day simple moving average of $12.64. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.39 and a current ratio of 0.60. Coloplast A/S has a 12 month low of $9.90 and a 12 month high of $14.34.

Coloplast A/S (OTCMKTS:CLPBY) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $0.08 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.08. Coloplast A/S had a net margin of 19.45% and a return on equity of 36.74%. The company had revenue of $959.05 million for the quarter. Sell-side analysts anticipate that Coloplast A/S will post 0.34 earnings per share for the current fiscal year.

Coloplast A/S Cuts Dividend

The business also recently announced a dividend, which was paid on Tuesday, May 28th. Stockholders of record on Monday, May 20th were issued a dividend of $0.0463 per share. The ex-dividend date was Friday, May 17th. Coloplast A/S’s dividend payout ratio (DPR) is presently 27.27%.

Coloplast A/S Company Profile

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.